NAYA — INVO Fertility Share Price
0.000.00%
Last trade - 00:00- $1.28m
- $3.66m
- $3.02m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.21 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -70.03% | ||
| Return on Equity | -4273.27% | ||
| Operating Margin | -94.05% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1.48 | 1.04 | 4.16 | 0.82 | 3.02 | 6.35 | 6.98 | 43.62% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
INVO Fertility Inc., formerly NAYA Biosciences, Inc., is a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition, and operation of fertility clinics. It focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, vitro fertilization (IVF) clinics. It has two operational INVO Centers in the United States and one IVF clinic. It is also engaged in the sale and distribution of its INVOcell technology solution into third-party owned and operated fertility clinics. The INVOcell is a proprietary medical device that allow fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.
Directors
- Steven Shum CEO (51)
- Andrea Goren CFO (53)
- Michael Campbell COO (63)
- Barbara Levy SVP
- Britt Carlsson VPR
- Meryle Chamberlain DMK
- Kevin Doody DRC (62)
- Trent Davis IND (53)
- Rebecca Messina IND (49)
- Barbara Ryan IND (61)
- Jeffrey Segal IND (62)
- Matthew Szot IND (46)
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- July 11th, 2005
- Public Since
- November 11th, 2008
- No. of Shareholders
- 191
- No. of Employees
- 25
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 666,057
- Address
- 5582 Broadcast Court, SARASOTA, 34240
- Web
- https://www.invobioscience.com/
- Phone
- +1 9788789505
- Contact
- Robert Blum
- Auditors
- M&K CPAS, PLLC
Upcoming Events for NAYA
Q2 2025 INVO Bioscience Inc Earnings Release
Similar to NAYA
Accelerate Diagnostics
NASDAQ Capital Market
Adagio Medical Holdings
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
Agape ATP
NASDAQ Capital Market
FAQ
What is the INVO Fertility share price?
As of Today at 22:12 UTC, shares in INVO Fertility are trading at $1.92. This share price information is delayed by 15 minutes.
How has the INVO Fertility share price performed this year?
Shares in INVO Fertility last closed at $1.92 and the price had moved by -91.21% over the past 365 days. In terms of relative price strength the INVO Fertility share price has underperformed the S&P500 Index by -91.73% over the past year.
What are the analyst and broker recommendations for INVO Fertility?
The overall consensus recommendation for INVO Fertility is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the INVO Fertility dividend yield?
INVO Fertility does not currently pay a dividend.
Does INVO Fertility pay a dividend?
INVO Fertility does not currently pay a dividend.
When does INVO Fertility next pay dividends?
INVO Fertility does not currently pay a dividend.
How do I buy INVO Fertility shares?
To buy shares in INVO Fertility you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of INVO Fertility?
As of the previous close price of $1.92, shares in INVO Fertility had a market capitalisation of $1.28m.
Where are INVO Fertility shares listed?
Here are the trading details for INVO Fertility:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: NAYA
What kind of share is INVO Fertility?
Based on an overall assessment of its quality, value and momentum INVO Fertility is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a INVO Fertility share price forecast for 2025?
The analyst consensus target price for shares in INVO Fertility is $24.00. That is 1150% above the last closing price of $1.92.
Analysts covering INVO Fertility currently have a consensus Earnings Per Share (EPS) forecast of -$15.48 for the next financial year.
Find out moreWhat is the trend in the INVO Fertility share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like INVO Fertility. Over the past six months, its share price has underperformed the S&P500 Index by -79.34%.
As of the last closing price of $1.92, shares in INVO Fertility were trading -75.39% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the INVO Fertility PE Ratio?
The INVO Fertility PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.92.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of INVO Fertility?
INVO Fertility's management team is headed by:
- Steven Shum - CEO
- Andrea Goren - CFO
- Michael Campbell - COO
- Barbara Levy - SVP
- Britt Carlsson - VPR
- Meryle Chamberlain - DMK
- Kevin Doody - DRC
- Trent Davis - IND
- Rebecca Messina - IND
- Barbara Ryan - IND
- Jeffrey Segal - IND
- Matthew Szot - IND